KINISOQUIN FX Trademark

Trademark Overview

On Monday, March 16, 2020, a trademark application was filed for KINISOQUIN FX with the United States Patent and Trademark Office. The USPTO has given the KINISOQUIN FX trademark a serial number of 88836229. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Quercis Pharma AG. The KINISOQUIN FX trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
kinisoquin fx

General Information

Serial Number88836229
Word MarkKINISOQUIN FX
Filing DateMonday, March 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Translation of Words in MarkThe wording "KINISOQUIN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuercis Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressZug 6300
CH
Party NameQuercis Pharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Wednesday, July 15, 2020ASSIGNED TO EXAMINER
Thursday, March 19, 2020NEW APPLICATION ENTERED
Friday, March 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 17, 2020NON-FINAL ACTION WRITTEN
Friday, July 17, 2020NON-FINAL ACTION E-MAILED
Friday, July 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 20, 2021SOU EXTENSION 1 FILED
Wednesday, October 20, 2021SOU EXTENSION 1 GRANTED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 2 FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, June 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 25, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, July 25, 2022PETITION TO REVIVE-GRANTED
Monday, July 25, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 25, 2022NOTICE OF REVIVAL - E-MAILED
Monday, August 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 19, 2022SOU EXTENSION 3 FILED
Wednesday, October 19, 2022SOU EXTENSION 3 GRANTED
Friday, October 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 20, 2023SOU EXTENSION 4 FILED
Thursday, April 20, 2023SOU EXTENSION 4 GRANTED
Saturday, April 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023SOU EXTENSION 5 FILED
Monday, October 23, 2023SOU EXTENSION 5 GRANTED
Tuesday, October 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

kinisoquin cancer disease pancreatic sclerosis lateral ovarian covid virus ebola amyotrophic